CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on human embryonic stem cells, exploring their potential in regenerative medicine and drug discovery. It aims to improve gene transfer methods for creating genetically modified stem cell lines, which could enhance their therapeutic applications and understanding of genetic diseases.
Human embryonic stem cells (hESC) are pluripotent cells derived from blastocyst stage early embryos.
Since the original publication a vast number of studies have described the differentiation of hESC and their potential in regenerative medicine.
It is now well known that hESC might be used in cell replacement therapies in a number of severe degenrative diseases like Type I diabetes or Parkinson’s disease.
In addition, hESCs and their derivatives could be used as tools in discovering new drugs an…
THE UNIVERSITY OF SHEFFIELD
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
